{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:23:30Z","timestamp":1793132610165,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["VI.Veni.202.045"],"award-info":[{"award-number":["VI.Veni.202.045"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016882","name":"European Resuscitation Council","doi-asserted-by":"publisher","award":["758913"],"award-info":[{"award-number":["758913"]}],"id":[{"id":"10.13039\/100016882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-18-2-0015"],"award-info":[{"award-number":["W81XWH-18-2-0015"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-18-2-0017"],"award-info":[{"award-number":["W81XWH-18-2-0017"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-18-2-0018"],"award-info":[{"award-number":["W81XWH-18-2-0018"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-18-2-0016"],"award-info":[{"award-number":["W81XWH-18-2-0016"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-18-2-0019"],"award-info":[{"award-number":["W81XWH-18-2-0019"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-18-2-0013"],"award-info":[{"award-number":["W81XWH-18-2-0013"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000771","name":"Prostate Cancer UK","doi-asserted-by":"publisher","award":["RIA21-ST2-006"],"award-info":[{"award-number":["RIA21-ST2-006"]}],"id":[{"id":"10.13039\/501100000771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000771","name":"Prostate Cancer UK","doi-asserted-by":"publisher","award":["TLD-PF19-002"],"award-info":[{"award-number":["TLD-PF19-002"]}],"id":[{"id":"10.13039\/501100000771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000771","name":"Prostate Cancer UK","doi-asserted-by":"publisher","award":["RIA16-ST2-011"],"award-info":[{"award-number":["RIA16-ST2-011"]}],"id":[{"id":"10.13039\/501100000771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014599","name":"Mark Foundation For Cancer Research","doi-asserted-by":"publisher","award":["6961"],"award-info":[{"award-number":["6961"]}],"id":[{"id":"10.13039\/100014599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","award":["MR\/Y022947\/1"],"award-info":[{"award-number":["MR\/Y022947\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","award":["MC\/PC\/18057"],"award-info":[{"award-number":["MC\/PC\/18057"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R015902\/1"],"award-info":[{"award-number":["MR\/R015902\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ebiom.2024.105163","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T13:08:06Z","timestamp":1716210486000},"page":"105163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone"],"prefix":"10.1016","volume":"104","author":[{"given":"Kirsty","family":"Hodgson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6180-7882","authenticated-orcid":false,"given":"Margarita","family":"Orozco-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Archer","family":"Goode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Garnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Beatson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Livermore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline A.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3668-2034","authenticated-orcid":false,"given":"Johan FA.","family":"Pijnenborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke","family":"Eerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam J.","family":"Moons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6381-6475","authenticated-orcid":false,"given":"Emiel","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Hysenaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashi","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqian","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyla Putri","family":"Nangkana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward N.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Duxfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella P.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Heer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Macauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"B\u00fcll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Boltje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2663-7515","authenticated-orcid":false,"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8631-4531","authenticated-orcid":false,"given":"Jennifer","family":"Munkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib1","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ebiom.2024.105163_bib2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2022.01.015","article-title":"Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer","volume":"530","author":"Kang","year":"2022","journal-title":"Cancer Lett"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105163_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3892\/ol.2023.13749","article-title":"Prostate cancer bone metastases biology and clinical management (Review)","volume":"25","author":"Archer Goode","year":"2023","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ebiom.2024.105163_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2490-10-23","article-title":"Pathologic fracture and metastatic spinal cord compression in patients with prostate cancer and bone metastases","volume":"10","author":"Nieder","year":"2010","journal-title":"BMC Urol"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105163_bib5","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"23","key":"10.1016\/j.ebiom.2024.105163_bib6","doi-asserted-by":"crossref","first-page":"35478","DOI":"10.18632\/oncotarget.8155","article-title":"Hallmarks of glycosylation in cancer","volume":"7","author":"Munkley","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105163_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41573-020-00093-1","article-title":"The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans","volume":"20","author":"Smith","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ccell.2019.06.006","article-title":"Glycosylation in the era of cancer-targeted therapy: where are we heading?","volume":"36","author":"Mereiter","year":"2019","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105163_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s13402-023-00770-4","article-title":"Aberrant N-glycosylation in cancer: MGAT5 and beta1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression","volume":"46","author":"de-Souza-Ferreira","year":"2023","journal-title":"Cell Oncol (Dordr)"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105163_bib10","first-page":"983","article-title":"ST6GAL1: a key player in cancer","volume":"18","author":"Garnham","year":"2019","journal-title":"Oncol Lett"},{"issue":"4801","key":"10.1016\/j.ebiom.2024.105163_bib11","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1126\/science.2953071","article-title":"Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis","volume":"236","author":"Dennis","year":"1987","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.ebiom.2024.105163_bib12","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.3390\/cancers14174248","article-title":"Aberrant sialylation in cancer: therapeutic opportunities","volume":"14","author":"Munkley","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105163_bib13","first-page":"102","article-title":"Targeting aberrant sialylation to treat cancer","volume":"6","author":"Munkley","year":"2019","journal-title":"Medicines (Basel)"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105163_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/cancers10060207","article-title":"Hypersialylation in cancer: modulation of inflammation and therapeutic opportunities","volume":"10","author":"Rodrigues","year":"2018","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105163_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/glycob\/cwv097","article-title":"Sialic acids in cancer biology and immunity","volume":"26","author":"Pearce","year":"2016","journal-title":"Glycobiology"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105163_bib16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/glycob\/cwaa110","article-title":"Regulation of ST6GAL1 sialyltransferase expression in cancer cells","volume":"31","author":"Dorsett","year":"2021","journal-title":"Glycobiology"},{"key":"10.1016\/j.ebiom.2024.105163_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.962908","article-title":"ST6Gal1: oncogenic signaling pathways and targets","volume":"9","author":"Gc","year":"2022","journal-title":"Front Mol Biosci"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41698-023-00363-2","article-title":"Rewiring of the N-Glycome with prostate cancer progression and therapy resistance","volume":"7","author":"Butler","year":"2023","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41598-023-50957-w","article-title":"An N-glycome tissue atlas of 15 human normal and cancer tissue types determined by MALDI-imaging mass spectrometry","volume":"14","author":"Wallace","year":"2024","journal-title":"Sci Rep"},{"issue":"40","key":"10.1016\/j.ebiom.2024.105163_bib20","doi-asserted-by":"crossref","first-page":"65374","DOI":"10.18632\/oncotarget.11699","article-title":"ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K\/Akt\/GSK-3beta\/beta-catenin signaling pathway","volume":"7","author":"Wei","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2024.105163_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ebiom.2016.04.018","article-title":"Glycosylation is an androgen-regulated process essential for prostate cancer cell viability","volume":"8","author":"Munkley","year":"2016","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/path.6152","article-title":"ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression","volume":"261","author":"Scott","year":"2023","journal-title":"J\u00a0Pathol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105163_bib23","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1021\/acs.jmedchem.8b01757","article-title":"Potent metabolic sialylation inhibitors based on C-5-Modified fluorinated sialic acids","volume":"62","author":"Heise","year":"2019","journal-title":"J\u00a0Med Chem"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105163_bib24","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1021\/acschembio.1c00868","article-title":"Structure-activity relationship of metabolic sialic acid inhibitors and labeling reagents","volume":"17","author":"Moons","year":"2022","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.ebiom.2024.105163_bib25","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.47678","article-title":"Androgen-regulated transcription of ESRP2 drives alternative splicing patterns in prostate cancer","volume":"8","author":"Munkley","year":"2019","journal-title":"Elife"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105163_bib26","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/s41388-023-02604-x","article-title":"Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth","volume":"42","author":"Scott","year":"2023","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43019-8","article-title":"The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer","volume":"13","author":"Hodgson","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib28","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1038\/s41598-017-05489-5","article-title":"The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration","volume":"7","author":"Munkley","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105163_bib29","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1158\/1078-0432.CCR-19-0098","article-title":"Transient Sox9 expression facilitates resistance to androgen-targeted therapy in prostate cancer","volume":"26","author":"Nouri","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ebiom.2024.105163_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40644-016-0068-2","article-title":"Prostate MRI based on PI-RADS version 2: how we review and report","volume":"16","author":"Steiger","year":"2016","journal-title":"Cancer Imag"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105163_bib31","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1590\/S1677-5538.IBJU.2014.0251","article-title":"Prostate cancer volume estimations based on transrectal ultrasonography-guided biopsy in order to predict clinically significant prostate cancer","volume":"41","author":"Konyalioglu","year":"2015","journal-title":"Int Braz J Urol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105163_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.eururo.2011.05.006","article-title":"The contemporary concept of significant versus insignificant prostate cancer","volume":"60","author":"Ploussard","year":"2011","journal-title":"Eur Urol"},{"issue":"19","key":"10.1016\/j.ebiom.2024.105163_bib33","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1021\/acs.analchem.2c04882","article-title":"Bioorthogonal chemical labeling probes targeting sialic acid isomers for N-glycan MALDI imaging mass spectrometry of tissues, cells, and biofluids","volume":"95","author":"Lu","year":"2023","journal-title":"Anal Chem"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/cpps.68","article-title":"In situ imaging of N-glycans by MALDI imaging mass spectrometry of fresh or formalin-fixed paraffin-embedded tissue","volume":"94","author":"Drake","year":"2018","journal-title":"Curr Protoc Protein Sci"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105163_bib35","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/pros.23957","article-title":"Syngeneic murine model for prostate cancer using RM1 cells transfected with gp100","volume":"80","author":"Yeon","year":"2020","journal-title":"Prostate"},{"issue":"16","key":"10.1016\/j.ebiom.2024.105163_bib36","first-page":"3325","article-title":"Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model","volume":"57","author":"Foster","year":"1997","journal-title":"Cancer Res"},{"issue":"15","key":"10.1016\/j.ebiom.2024.105163_bib37","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/pros.21010","article-title":"A\u00a0novel model of bone-metastatic prostate cancer in immunocompetent mice","volume":"69","author":"Power","year":"2009","journal-title":"Prostate"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105163_bib38","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105163_bib40","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/jbmr.4010","article-title":"CRELD2 is a novel LRP1 chaperone that regulates noncanonical WNT signaling in skeletal development","volume":"35","author":"Dennis","year":"2020","journal-title":"J\u00a0Bone Miner Res"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105163_bib41","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/glycob\/cwad085","article-title":"Targeting aberrant sialylation and fucosylation in prostate cancer cells using potent metabolic inhibitors","volume":"33","author":"Orozco-Moreno","year":"2023","journal-title":"Glycobiology"},{"issue":"W1","key":"10.1016\/j.ebiom.2024.105163_bib42","doi-asserted-by":"crossref","first-page":"W345","DOI":"10.1093\/nar\/gkac247","article-title":"The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update","volume":"50","author":"Galaxy","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet J"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105163_bib44","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat Methods"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105163_bib45","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105163_bib46","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"voom: precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.ebiom.2024.105163_bib47","series-title":"ggplot2: elegant graphics for data analysis","author":"Whickham","year":"2016"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105163_bib48","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2010-11-2-r14","article-title":"Gene ontology analysis for RNA-seq: accounting for selection bias","volume":"11","author":"Young","year":"2010","journal-title":"Genome Biol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105163_bib49","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/bioinformatics\/btw623","article-title":"Combining multiple tools outperforms individual methods in gene set enrichment analyses","volume":"33","author":"Alhamdoosh","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ebiom.2024.105163_bib50","series-title":"gplots: various R programming tools for plotting data","year":"2015"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib51","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1038\/s41467-020-18907-6","article-title":"A\u00a0versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands","volume":"11","author":"Rodrigues","year":"2020","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105163_bib52","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105163_bib53","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.eururo.2017.03.027","article-title":"Molecular subgroup of primary prostate cancer presenting with metastatic biology","volume":"72","author":"Walker","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.ebiom.2024.105163_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.734280","article-title":"Direct N-glycosylation profiling of urine and prostatic fluid glycoproteins and extracellular vesicles","volume":"9","author":"Blaschke","year":"2021","journal-title":"Front Chem"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105163_bib55","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.3390\/ijms20102528","article-title":"Core-fucosylated tetra-antennary N-glycan containing A single N-acetyllactosamine branch is associated with poor survival outcome in breast cancer","volume":"20","author":"Herrera","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2024.105163_bib56","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-1-4939-8997-3_16","article-title":"Models of prostate cancer bone metastasis","volume":"1914","author":"Park","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105163_bib57","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1021\/acschembio.1c00689","article-title":"A\u00a0useful guide to lectin binding: machine-learning directed annotation of 57 unique lectin specificities","volume":"17","author":"Bojar","year":"2022","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.ebiom.2024.105163_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146240","article-title":"Inhibitor of DNA binding 2 knockdown inhibits the growth and liver metastasis of colorectal cancer","volume":"819","author":"Liu","year":"2022","journal-title":"Gene"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105163_bib59","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/carcin\/bgs226","article-title":"Desmoplakin acts as a tumor suppressor by inhibition of the Wnt\/beta-catenin signaling pathway in human lung cancer","volume":"33","author":"Yang","year":"2012","journal-title":"Carcinogenesis"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105163_bib60","first-page":"3058","article-title":"Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models","volume":"60","author":"Miyake","year":"2000","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105163_bib61","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s12276-020-0484-z","article-title":"The M-CSF receptor in osteoclasts and beyond","volume":"52","author":"Mun","year":"2020","journal-title":"Exp Mol Med"},{"issue":"436","key":"10.1016\/j.ebiom.2024.105163_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan3311","article-title":"T\u00a0cell-induced CSF1 promotes melanoma resistance to PD1 blockade","volume":"10","author":"Neubert","year":"2018","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105163_bib63","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/1535-7163.MCT-20-0591","article-title":"CSF1\/CSF1R signaling inhibitor pexidartinib (PLX3397) reprograms tumor-associated macrophages and stimulates T-cell infiltration in the sarcoma microenvironment","volume":"20","author":"Fujiwara","year":"2021","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105163_bib64","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1158\/1535-7163.MCT-16-0866","article-title":"Colony-stimulating factor 1 receptor blockade inhibits tumor growth by altering the polarization of tumor-associated macrophages in hepatocellular carcinoma","volume":"16","author":"Ao","year":"2017","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105163_bib65","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1182\/blood-2011-09-379214","article-title":"Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling","volume":"119","author":"Hume","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.581","article-title":"Subversion of infiltrating prostate macrophages to a mixed immunosuppressive tumor-associated macrophage phenotype","volume":"12","author":"Boibessot","year":"2022","journal-title":"Clin Transl Med"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib67","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1038\/s41467-018-05346-7","article-title":"Macrophages are exploited from an innate wound healing response to facilitate cancer metastasis","volume":"9","author":"Muliaditan","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib69","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1038\/s41467-021-26840-5","article-title":"Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression","volume":"12","author":"Bolis","year":"2021","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105163_bib70","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.euo.2018.09.014","article-title":"Mannose receptor-positive macrophage infiltration correlates with prostate cancer onset and metastatic castration-resistant disease","volume":"2","author":"Zarif","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.ebiom.2024.105163_bib71","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cca.2019.12.015","article-title":"Tumour associated glycans: a route to boost immunotherapy?","volume":"502","author":"Scott","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib72","doi-asserted-by":"crossref","first-page":"1R","DOI":"10.1093\/glycob\/cwj008","article-title":"Siglecs--the major subfamily of I-type lectins","volume":"16","author":"Varki","year":"2006","journal-title":"Glycobiology"},{"issue":"17","key":"10.1016\/j.ebiom.2024.105163_bib73","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2026102118","article-title":"Probing the binding specificities of human Siglecs by cell-based glycan arrays","volume":"118","author":"Bull","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib74","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41598-023-27634-z","article-title":"Simplifying the detection and monitoring of protein glycosylation during in\u00a0vitro glycoengineering","volume":"13","author":"Saunders","year":"2023","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105163_bib75","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nrurol.2016.65","article-title":"The role of glycans in the development and progression of prostate cancer","volume":"13","author":"Munkley","year":"2016","journal-title":"Nat Rev Urol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105163_bib76","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3390\/ijms20061389","article-title":"Glycans as biomarkers in prostate cancer","volume":"20","author":"Scott","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105163_bib77","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc.2017.6","article-title":"Pre-metastatic niches: organ-specific homes for metastases","volume":"17","author":"Peinado","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105163_bib78","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144579","article-title":"RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis","volume":"132","author":"Yue","year":"2022","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105163_bib79","first-page":"100","article-title":"The role of lysyl oxidase, the extracellular matrix and the pre-metastatic niche in bone metastasis","volume":"5","author":"Gartland","year":"2016","journal-title":"J\u00a0Bone Oncol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105163_bib80","first-page":"570","article-title":"The vicious cycle of bone metastases","volume":"2","author":"Guise","year":"2002","journal-title":"J\u00a0Musculoskelet Neuronal Interact"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105163_bib81","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.trecan.2020.09.006","article-title":"Emerging players in prostate cancer-bone niche communication","volume":"7","author":"Furesi","year":"2021","journal-title":"Trends Cancer"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105163_bib82","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41417-022-00485-y","article-title":"Extracellular sialyltransferase st6gal1 in breast tumor cell growth and invasiveness","volume":"29","author":"Hait","year":"2022","journal-title":"Cancer Gene Ther"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105163_bib83","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.trecan.2019.10.013","article-title":"Unmasking the many faces of tumor-associated neutrophils and macrophages: considerations for targeting innate immune cells in cancer","volume":"5","author":"Keeley","year":"2019","journal-title":"Trends Cancer"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105163_bib84","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","article-title":"Single-cell map of diverse immune phenotypes in the breast tumor microenvironment","volume":"174","author":"Azizi","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib85","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13059-017-1362-4","article-title":"Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment","volume":"18","author":"Muller","year":"2017","journal-title":"Genome Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib86","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/s41598-024-52073-9","article-title":"Periodontal ligament cells-derived exosomes promote osteoclast differentiation via modulating macrophage polarization","volume":"14","author":"Bai","year":"2024","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105163_bib87","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.eururo.2016.07.033","article-title":"Subgroups of castration-resistant prostate cancer bone metastases defined through an inverse relationship between androgen receptor activity and immune response","volume":"71","author":"Ylitalo","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.ebiom.2024.105163_bib88","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.3389\/fimmu.2018.02629","article-title":"Targeting macrophage-recruiting chemokines as a novel therapeutic strategy to prevent the progression of solid tumors","volume":"9","author":"Argyle","year":"2018","journal-title":"Front Immunol"},{"issue":"47","key":"10.1016\/j.ebiom.2024.105163_bib89","doi-asserted-by":"crossref","first-page":"83261","DOI":"10.18632\/oncotarget.18743","article-title":"Prognostic role of tumour-associated macrophages and macrophage scavenger receptor 1 in prostate cancer: a systematic review and meta-analysis","volume":"8","author":"Cao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2024.105163_bib90","article-title":"Prostate cancer-induced endothelial-to-osteoblast transition generates an immunosuppressive bone tumor microenvironment","author":"Yu","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.ebiom.2024.105163_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105163_bib92","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2174\/1389450120666190123141553","article-title":"A\u00a0review of preclinical experiments toward targeting M2 macrophages in prostate cancer","volume":"20","author":"Seif","year":"2019","journal-title":"Curr Drug Targets"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib93","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/s41467-021-21550-4","article-title":"Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9","volume":"12","author":"Rodriguez","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib94","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s42003-020-01359-5","article-title":"Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype","volume":"3","author":"Beatson","year":"2020","journal-title":"Commun Biol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105163_bib95","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nri.2018.3","article-title":"The tumour glyco-code as a novel immune checkpoint for immunotherapy","volume":"18","author":"RodrIguez","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105163_bib96","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nri3737","article-title":"Siglec-mediated regulation of immune cell function in disease","volume":"14","author":"Macauley","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105163_bib97","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2567.2007.02752.x","article-title":"CD22: an inhibitory enigma","volume":"123","author":"Walker","year":"2008","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib98","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41467-017-00836-6","article-title":"Molecular basis of human CD22 function and therapeutic targeting","volume":"8","author":"Ereno-Orbea","year":"2017","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105163_bib99","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3390\/cancers15030920","article-title":"Immune-activated B cells are dominant in prostate cancer","volume":"15","author":"Saudi","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ebiom.2024.105163_bib100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1479-5876-12-30","article-title":"Tumor infiltrating B-cells are increased in prostate cancer tissue","volume":"12","author":"Woo","year":"2014","journal-title":"J\u00a0Transl Med"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib101","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/s41467-021-21245-w","article-title":"Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes","volume":"12","author":"Weiner","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2024.105163_bib102","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2024.105163_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2022.101112","article-title":"Siglec receptors as new immune checkpoints in cancer","volume":"90","author":"Stanczak","year":"2023","journal-title":"Mol Aspects Med"},{"issue":"7714","key":"10.1016\/j.ebiom.2024.105163_bib104","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41586-018-0266-0","article-title":"IL-23 secreted by myeloid cells drives castration-resistant prostate cancer","volume":"559","author":"Calcinotto","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105163_bib105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/cjp2.160","article-title":"Polymorphonuclear MDSCs are enriched in the stroma and expanded in metastases of prostate cancer","volume":"6","author":"Wen","year":"2020","journal-title":"J\u00a0Pathol Clin Res"},{"issue":"13","key":"10.1016\/j.ebiom.2024.105163_bib106","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1158\/0008-5472.CAN-17-3376","article-title":"Sialic acid blockade suppresses tumor growth by enhancing T-cell-mediated tumor immunity","volume":"78","author":"Bull","year":"2018","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib107","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1021\/nn5061964","article-title":"Targeted delivery of a sialic acid-blocking glycomimetic to cancer cells inhibits metastatic spread","volume":"9","author":"Bull","year":"2015","journal-title":"ACS Nano"},{"issue":"51","key":"10.1016\/j.ebiom.2024.105163_bib108","doi-asserted-by":"crossref","first-page":"35149","DOI":"10.1074\/jbc.M114.606517","article-title":"Systemic blockade of sialylation in mice with a global inhibitor of sialyltransferases","volume":"289","author":"Macauley","year":"2014","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105163_bib109","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.it.2020.02.001","article-title":"Sialoglycans and Siglecs can shape the tumor immune microenvironment","volume":"41","author":"van de Wall","year":"2020","journal-title":"Trends Immunol"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105163_bib110","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41589-020-0622-x","article-title":"Targeted glycan degradation potentiates the anticancer immune response in\u00a0vivo","volume":"16","author":"Gray","year":"2020","journal-title":"Nat Chem Biol"},{"issue":"669","key":"10.1016\/j.ebiom.2024.105163_bib111","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj1270","article-title":"Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade","volume":"14","author":"Stanczak","year":"2022","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105163_bib112","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s42003-024-05924-0","article-title":"ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer","volume":"7","author":"Garnham","year":"2024","journal-title":"Commun Biol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105163_bib113","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1158\/0008-5472.CAN-14-0992","article-title":"CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy","volume":"75","author":"Escamilla","year":"2015","journal-title":"Cancer Res"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424001981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424001981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:48:48Z","timestamp":1770050928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424001981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":113,"alternative-id":["S2352396424001981"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105163","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105163"}}